Literature DB >> 1437282

The spectrum of presentation at autopsy of myocarditis in infancy and childhood.

N M Smith1, A J Bourne, W K Clapton, R W Byard.   

Abstract

To characterize the clinicopathological presentation of patients with myocarditis coming to autopsy in childhood, 32 cases of histologically-proven myocarditis were obtained from the files of the Adelaide Children's Hospital. In 16 of the cases (Group A), myocarditis was the only significant finding and death was ascribed to this condition. In the remaining 16 (Group B) myocarditis was found in association with other severe disease processes. Clinical histories of the 2 groups showed sudden death to be a feature in 5 out of 16 cases in Group A, 3 of whom had no prodromal symptoms. Five patients in Group B also suffered sudden death, but this was associated with a variety of causes, including bronchopneumonia, and asphyxia. These cases demonstrate the variability in clinicopathological presentation of myocarditis in infancy and childhood and suggest that myocarditis should always be considered a possible diagnosis at autopsy in the pediatric age group, even in the presence of coincident lethal disease.

Entities:  

Mesh:

Year:  1992        PMID: 1437282     DOI: 10.3109/00313029209063159

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

Review 1.  Diagnosis and management of pediatric myocarditis.

Authors:  Desmond Bohn; Lee Benson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Pediatric patients hospitalized with myocarditis: a multi-institutional analysis.

Authors:  Darren Klugman; John T Berger; Craig A Sable; Jianping He; Sachin G Khandelwal; Anthony D Slonim
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

3.  Heart block and sudden death associated with fibrosis of the conduction system at the margin of a ventricular septal defect.

Authors:  N M Smith; S Y Ho
Journal:  Pediatr Cardiol       Date:  1994 May-Jun       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.